Early experience with universal preprocedural testing for SARS-CoV-2 in a relatively low-prevalence area.

Published online

Journal Article

We implemented universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing of patients undergoing surgical procedures as a means to conserve personal protective equipment (PPE). The rate of asymptomatic coronavirus disease 2019 (COVID-19) was <0.5%, which suggests that early local public health interventions were successful. Although our protocol was resource intensive, it prevented exposures to healthcare team members.

Full Text

Duke Authors

Cited Authors

  • Lewis, SS; Smith, BA; Akinboyo, IC; Seidelman, J; Wolfe, C; Kirk, AB; Martin, G; Denny, T; Lobaugh, B; Rehder, C; Cardona, D; Lee, MJ; Polage, CR; Datto, MB

Published Date

  • August 3, 2020

Published In

Start / End Page

  • 1 - 3

PubMed ID

  • 32741409

Pubmed Central ID

  • 32741409

Electronic International Standard Serial Number (EISSN)

  • 1559-6834

Digital Object Identifier (DOI)

  • 10.1017/ice.2020.398

Language

  • eng

Conference Location

  • United States